Kala Pharmaceuticals, Inc.
(NASDAQ : KALA)

( )
KALA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
1.75%131.320.7%$869.57m
PFEPfizer Inc.
0.92%36.120.9%$677.48m
MRKMerck & Co., Inc.
0.33%84.590.7%$653.74m
ABBVAbbVie, Inc.
0.29%73.592.3%$567.84m
BMYBristol-Myers Squibb Company
1.64%51.611.4%$507.77m
LLYEli Lilly and Company
1.32%108.331.0%$317.22m
NVSNovartis AG Sponsored ADR
-0.99%85.750.2%$154.52m
AZNAstraZeneca PLC Sponsored ADR
0.71%43.891.2%$152.54m
GSKGlaxoSmithKline plc Sponsored ADR
-0.14%42.190.3%$93.41m
SNYSanofi Sponsored ADR
-0.31%44.810.2%$82.63m
NVONovo Nordisk A/S Sponsored ADR Class B
1.80%52.150.1%$75.49m
LCILannett Company, Inc.
-0.18%11.0735.6%$19.29m
AKTXAkari Therapeutics Plc Sponsored ADR
-0.55%1.821.6%$0.76m
EPIXESSA Pharma Inc
6.20%3.300.1%$0.08m

Company Profile

Kala Pharmaceuticals, Inc. is a biopharmaceutical company, focused on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Waltham, MA.